In wild type mice inoculated with VMR-RANTES cells, we monitored lesions in lungs (6/6), liver (6/6), and other organs (4/6), whereas wild type mice inoculated with VMR-mock cells displayed little or no metastasis at this time-point.
To address this important issue, we employed multimodal MRI at ultra-high-field strength (UHF-MRI) to monitor lesion development in relation to cerebral blood flow in GPIb-Fab-treated mice and naive controls after tMCAO.
However, this color change was not used to monitor lesion progression.
They were then checked weekly to monitor lesion progression and, 5 weeks from the beginning of the experiments, anesthetised, bled and killed.
Individuals who did not present lesions initially were followed up for 8 months post-deployment to monitor lesion appearance and were recommended not to travel to endemic areas during that period.
Studies have already shown that QLF might be useful in monitoring lesions while engaging in remineralization therapies.
To study the Dll4/Notch function in mouse skin tumors and evaluate the effect of its suppression, we monitored skin lesion formation and evolution in WT and Dll4+/− mice during 20 weeks.
All of these factors impair the effectiveness of clinical monitoring, lesion identification, and operation with US guidance.
The in vivo pathogenicity of selected virus preparations was assessed in mice by monitoring lesion severity for 14 days following inoculation of the left ear pinna with 5 × 10 PFU.
Where the data were available, we monitored individual lesions longitudinally until they progressed.
